Resistance to Oral Therapy in Lung Cancer

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

July 1, 2020

Study Completion Date

November 28, 2020

Conditions
Non Small Cell Lung Cancer
Interventions
OTHER

Description of the molecular alterations detected in blood samples of patients treated by osimertinib

Description of the molecular alterations detected in blood samples of patients treated by osimertinib. This test is usualyy performed routinely to detect conventional mutations including EGFR T790M. We performed panel of genes screeining based on next generation sequencing. Thius, iIn some cases, new mutations can be detected by this assay.

Trial Locations (1)

34000

University Hospital, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04546282 - Resistance to Oral Therapy in Lung Cancer | Biotech Hunter | Biotech Hunter